A 78-year-old woman with an acute eosinophilic gastroenteritis

Javelle, Émilie; Gasperini, Guillaume; Mercier, J; Luciano, Laure; Sagui, Emmanuel; Soulier, Marie; Kerebel, Sébastien; Lebougeant, Patrick; Molinier, S.; Guisset, M.; Coton, T; Morand, Jean‐Jacques

doi:10.1016/j.clinre.2011.06.012

Cited by 3 publications

(3 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For such a diagnosis, skin, nerve, and muscle biopsies have been reported to have a sensitivity of 67.4%, 65.7%, and 47.9%, respectively (6). However, the utility of specimens obtained via an endoscopic biopsy of the GI tract in patients with EGPA has not been systematically investigated, although several case reports have been published (7)(8)(9)(10). In these reports, the histological findings have revealed eosinophilic infiltration in the mucosa, which is consistent with EGE.…”

Section: Discussionmentioning

confidence: 99%

Eosinophilic Granulomatosis with Polyangiitis Initially Diagnosed as Eosinophilic Gastroenteritis

et al. 2020

View full text Add to dashboard Cite

We herein report two cases of eosinophilic granulomatosis with polyangiitis (EGPA) initially diagnosed as eosinophilic gastroenteritis (EGE) based solely on endoscopic biopsy results. One year after the EGE diagnosis, one patient presented with multiple purpura, and skin biopsy findings resulted in a change of the diagnosis to EGPA. In another patient, multiple skin and colonic ulcerations emerged eight years after the diagnosis of EGE, at which time histological examinations of endoscopic biopsy specimens revealed vasculitis, and the diagnosis was changed to EGPA. Physicians should be aware of the possible existence of EGPA in cases diagnosed as EGE.

show abstract

Section: Discussionmentioning

confidence: 99%

Eosinophilic Granulomatosis with Polyangiitis Initially Diagnosed as Eosinophilic Gastroenteritis

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Gastric eosinophil infiltration has been described in several connective tissue diseases (CTD) including Churg-Strauss syndrome (124)(125)(126)(127), as well as in collagenous colitis (128). Benchimol et al (128) reported a 4-year-old girl with EoG associated with collagenous colitis.…”

Section: Connective Tissue Diseases With Vasculitis and Collagenous G...mentioning

confidence: 99%

Joint ESPGHAN/NASPGHAN Guidelines on Childhood Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis

Papadopoulou,

Amil‐Dias,

Auth

et al. 2024

J. pediatr. gastroenterol. nutr.

View full text Add to dashboard Cite

INTRODUCTION: Eosinophilic Gastrointestinal Disorders beyond Eosinophilic Esophagitis (non-EoE EGIDs) are rare chronic inflammatory disorders of the gastrointestinal (GI) tract. Diagnosis is based on clinical symptoms and histologic findings of eosinophilic inflammation after exclusion of a secondary cause or systemic disease. Currently, no guidelines exist for the evaluation of non-EoE EGIDs. Therefore, the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) formed a task force group to provide consensus guidelines for childhood non-EoE EGIDs. METHODS: The working group was composed of pediatric gastroenterologists, adult gastroenterologists, allergists/immunologists, and pathologists. An extensive electronic literature search of the MEDLINE, EMBASE, and Cochrane databases was conducted up to February 2022. General methodology was used in the formulation of recommendations according to the Appraisal of Guidelines for Research and Evaluation (AGREE) II and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system to meet current standards of evidence assessment. RESULTS: The guidelines provide information on the current concept of non-EoE EGIDs, disease pathogenesis, epidemiology, clinical manifestations, diagnostic and disease surveillance procedures, and current treatment options. Thirty-four statements based on available evidence and 41 recommendations based on expert opinion and best clinical practices were developed. CONCLUSION: Non-EoE EGIDs literature is limited in scope and depth, making clear recommendations difficult. These consensus-based clinical practice guidelines are intended to assist clinicians caring for children affected by non-EoE EGIDs and to facilitate high-quality randomized controlled trials of various treatment modalities using standardized, uniform disease definitions.

show abstract

“…Lymphocytic/lympho-histiocytic/apoptotic pattern [411][412][413][414][415][416][417][418] Some viral gastritis (ie, CMV, EBV, concurrent viral infection) GvHD-related gastritis Checkpoint inhibitor (ie, nivolumab, pembrolizumab)-related gastritis Predominant neutrophilic pattern [419][420][421][422][423] Bacterial/fungal gastritis Predominant eosinophilic pattern [424][425][426][427][428]…”

Section: Table 3 Acute Gastritis: Basic Histological Patternsmentioning

confidence: 99%

RE.GA.IN.: the Real-world Gastritis Initiative–updating the updates

Rugge,

Genta,

Malfertheiner

et al. 2024

Gut

View full text Add to dashboard Cite

At the end of the last century, a far-sighted ‘working party’ held in Sydney, Australia addressed the clinicopathological issues related to gastric inflammatory diseases. A few years later, an international conference held in Houston, Texas, USA critically updated the seminal Sydney classification. In line with these initiatives, Kyoto Global Consensus Report, flanked by the Maastricht-Florence conferences, added new clinical evidence to the gastritis clinicopathological puzzle.The most relevant topics related to the gastric inflammatory diseases have been addressed by the Real-world Gastritis Initiative (RE.GA.IN.), from disease definitions to the clinical diagnosis and prognosis. This paper reports the conclusions of the RE.GA.IN. consensus process, which culminated in Venice in November 2022 after more than 8 months of intense global scientific deliberations. A forum of gastritis scholars from five continents participated in the multidisciplinary RE.GA.IN. consensus. After lively debates on the most controversial aspects of the gastritis spectrum, the RE.GA.IN. Faculty amalgamated complementary knowledge to distil patient-centred, evidence-based statements to assist health professionals in their real-world clinical practice. The sections of this report focus on: the epidemiology of gastritis;Helicobacter pylorias dominant aetiology of environmental gastritis and as the most important determinant of the gastric oncogenetic field; the evolving knowledge on gastric autoimmunity; the clinicopathological relevance of gastric microbiota; the new diagnostic horizons of endoscopy; and the clinical priority of histologically reporting gastritis in terms of staging. The ultimate goal of RE.GA.IN. was and remains the promotion of further improvement in the clinical management of patients with gastritis.

show abstract

A 78-year-old woman with an acute eosinophilic gastroenteritis

Cited by 3 publications

References 19 publications

Eosinophilic Granulomatosis with Polyangiitis Initially Diagnosed as Eosinophilic Gastroenteritis

Eosinophilic Granulomatosis with Polyangiitis Initially Diagnosed as Eosinophilic Gastroenteritis

Joint ESPGHAN/NASPGHAN Guidelines on Childhood Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis

RE.GA.IN.: the Real-world Gastritis Initiative–updating the updates

Contact Info

Product

Resources

About